Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2025-06-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于启迪药业集团股份公司2024年度股东大会的法律意见书
Regulatory Filings
2025-06-26 Chinese
关于控股股东所持股份可能被司法拍卖暨公司控制权或将发生变更的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the judicial auction of shares held by the controlling shareholder, which may lead to a change in company control. It details the progress of the auction, risk warnings, and related legal and shareholder information. There are no financial statements, earnings data, or detailed financial analysis present. The document is a regulatory announcement about a significant legal and ownership event affecting the company, fitting the description of a Regulatory Filing (RNS) as it does not fit into more specific categories like M&A or Delisting. The document length is short (1823 characters), and it is not a report publication announcement or certification. Therefore, the best classification is Regulatory Filings (RNS).
2025-06-16 Chinese
2024年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled "2024年度股东大会" which translates to "2024 Annual General Meeting" and contains detailed meeting materials including the agenda, reports to be reviewed, voting procedures, and various proposals to be discussed and voted on at the 2024 Annual General Meeting scheduled for June 26, 2025. It includes references to the 2024 Annual Report, Board of Directors report, Supervisory Board report, financial statements, profit distribution plan, goodwill impairment proposals, and governance documents. The document is clearly a set of materials prepared for and used during the Annual General Meeting, not the Annual Report itself or any other standalone report. It is comprehensive and lengthy (15,000 characters), consistent with AGM materials. Therefore, the correct classification is AGM Information (AGM-R).
2025-06-03 Chinese
关于购买董事、监事及高级管理人员责任险的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the company's plan to purchase directors, supervisors, and senior management liability insurance. It includes details about the insurance plan, board and supervisory committee approvals, and the impact on the company. There are no financial statements, earnings data, or regulatory certifications. The document is a formal announcement about a governance-related insurance purchase, which relates to management and board matters but is not a report on management changes or remuneration. It fits best under Board/Management Information (MANG) as it concerns board-level risk management decisions and governance-related insurance coverage for directors and senior management.
2025-06-03 Chinese
第十届董事会临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a temporary board meeting of the company, including decisions about purchasing directors and officers liability insurance and scheduling the annual shareholders meeting. It includes voting results and references to other announcements for further details. The document does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is an official announcement of board decisions and meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2025-06-03 Chinese
关于召开2024年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of the company, including the date, time, venue, voting procedures, agenda items, and instructions for shareholders. It includes information about the proposals to be voted on, such as the 2024 annual report, board and supervisory reports, financial statements, profit distribution plan, and other corporate governance matters. The document does not contain the actual annual report or financial statements but rather serves as a formal notification and instructions for the AGM. The document length is 4525 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or notices about the AGM.
2025-06-03 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.